Riskpilot← Back to searchSign inGet full accessNØRREBRO FYSIOTERAPI ApS
APSActiveCVR 31269636Thorsgade 59, st. tvPhysiotherapy activities · NACE 8695Est. 200852 employees
Revenue 2025
DKK 25,5M
+12% vs 2024
EBITDA margin
23.7%
+14% vs 2024
Equity ratio
54.2%
Financial strength
Net profit 2025
DKK 4,1M
+17% vs 2024
| Revenue | DKK 25,5M | +12% |
| EBITDA | DKK 6,1M | +14% |
| Net profit | DKK 4,1M | +17% |
| Total assets | DKK 7,9M | +27% |
| Equity | DKK 4,3M | +60% |
| Employees | 52 | — |
Legal name
NØRREBRO FYSIOTERAPI ApS
CVR number
31269636
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
19. februar 2008
Share capital
DKK 40.000
Employees
52 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening
Company purpose
Selskabets formål er at drive virksomhed indenfor fysioterapibranchen
Address
Thorsgade 59, st. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.778 | — | — | 7.410 | 5.467 | 7.258 | 6.509 | 10.474 | 18.862 | 25.202 | 18.577 | 17.668 | 22.747 | 25.536 |
| Staff expenses | -2.404 | -3.080 | -4.267 | -4.557 | -4.498 | -5.013 | -4.902 | -9.263 | -18.209 | -24.125 | -17.008 | -16.043 | -17.446 | -19.482 |
| EBITDA | 1.374 | 1.704 | 1.316 | 2.853 | 969 | 2.245 | 1.607 | 1.178 | 653 | 1.029 | 1.569 | 1.573 | 5.301 | 6.054 |
| Depreciation & amort. | -481 | 473 | 460 | -487 | -511 | -633 | -721 | -776 | -776 | -1.070 | -590 | -600 | -635 | -743 |
| EBIT | 893 | 1.231 | 856 | 2.366 | 458 | 1.612 | 887 | 401 | -123 | -41 | 980 | 973 | 4.666 | 5.311 |
| Net financials | -487 | -397 | -316 | -184 | -73 | -88 | -83 | -169 | -67 | -71 | -56 | -113 | -148 | -27 |
| Profit before tax | 406 | 834 | 540 | 2.182 | 385 | 1.524 | 804 | 232 | -190 | -112 | 924 | 860 | 4.517 | 5.284 |
| Tax | 134 | 129 | 134 | 507 | 88 | 341 | 184 | 60 | -37 | -29 | 206 | 189 | 1.005 | 1.166 |
| Net profit | 272 | 705 | 406 | 1.675 | 297 | 1.183 | 620 | 172 | -153 | -83 | 717 | 671 | 3.512 | 4.118 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.536 | 6.479 | 6.278 | 6.355 | 6.551 | 7.712 | 7.686 | 8.219 | 8.595 | 6.788 | 6.087 | 5.906 | 6.230 | 7.933 |
| Equity | 614 | 1.018 | 1.125 | 2.500 | 2.198 | 2.781 | 2.651 | 2.164 | 1.562 | 834 | 152 | 823 | 2.685 | 4.303 |
| Long-term debt | 0 | 0 | 1.420 | 476 | 9 | 1.461 | 1.115 | 752 | 761 | 1.999 | 272 | 274 | 299 | 310 |
| Short-term debt | 5.702 | 5.111 | 3.250 | 2.465 | 3.492 | 2.703 | 3.240 | 4.710 | 4.311 | 3.547 | 5.257 | 4.419 | 2.806 | 2.782 |
| Total debt | 5.702 | 5.111 | 4.670 | 2.941 | 3.501 | 4.164 | 4.355 | 5.463 | 5.072 | 5.546 | 5.529 | 4.693 | 3.104 | 3.092 |
EBITDA margin
23.7%
This company
15.8%
Market median
+50% vs market
20122025
Equity ratio
54.2%
This company
38.2%
Market median
+42% vs market
20122025
Return on equity
95.7%
This company
18.4%
Market median
+420% vs market
20122025
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20122025
Asset turnover
3.22×
This company
1.12×
Market median
+188% vs market
20122025
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Management | Management | 2023 | — | — |
AL Management | Management | 2008 | — | — |
MK Management | Management | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ANDREAS LUND BØTTCHER HOLDING ApS | Company | 33.3% | 33.3% | 2008 |
Autoriseret fysioterapeut Korshøj Christensen Holding ApS | Company | 33.3% | 33.3% | 2025 |
SW Rådgivning ApS | Company | 25.0% | 25.0% | 2020 |
Autoriserede fysioterapeut Janick Møllerud Holding ApS | Company | 10.0% | 10.0% | 2022 |
| Individual | 25.0% | 25.0% | 2008 | |
| Individual | 25.0% | 25.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WOLFF INVESTMENT GROUP ApS
NØRREBRO FYSIOTERAPI ApS Board members of NØRREBRO FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Janick Høiseth Møllerud | Management | 0 companies |
| Andreas Lund Knudsen | Management | 0 companies |
| Mads Korshøj Christensen | Management | 0 companies |